<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>17</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>05</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Ceftazidime-avibactam activity against Escherichia coli and Klebsiella pneumoniae</title>
    <FirstPage>19</FirstPage>
    <LastPage>24</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Arun</FirstName>
        <LastName>Sachu</LastName>
        <affiliation locale="en_US">Department of Microbiology, Believers Church Medical College, Thiruvalla, Kerala, India</affiliation>
      </Author>
      <Author>
        <FirstName>Alice</FirstName>
        <LastName>David</LastName>
        <affiliation locale="en_US">Head of Medical Research, Believers Church Medical College, Thiruvalla, Kerala, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>07</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>01</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Carbapenem-resistant Enterobacteriaceae (CRE) infections are extremely difficult to treat and have a high fatality rate. The study's primary goal was to determine the rate of ceftazidime-avibactam susceptibility using disc diffusion and E-Test, as well as to evaluate the agreement between the two methods. 
Materials and Methods: A total of 124 multidrug-resistant (including carbapenem) Escherichia coli and Klebisella pneumoniae isolates were included. Kirby Bauer's disc diffusion and E-test were used as the testing methods in this study.
Results: In this study 37.5% and 33.9% of the isolates were susceptible to ceftazidime-avibactam by E test and Disc diffusion respectively. There were five isolates which produced discordant results. Among the 56 isolates there was 91% agreement between the two methods.
Conclusion: Among the discordant isolates the alarming disparity in zone size was a significant concern. Since CRE infections are very common, an economical and practical method for testing ceftazidime-avibactam susceptibility is needed in all the clinical microbiology laboratories as it is a last resort drug.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4901</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4901/1737</pdf_url>
  </Article>
</Articles>
